MediPal Holdings Corporation
MEPDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $3,671 | $3,559 | $3,360 | $3,291 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | $3,416 | $3,312 | $3,136 | $3,073 |
| Gross Profit | $256 | $247 | $224 | $217 |
| % Margin | 7% | 6.9% | 6.7% | 6.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $165 | $144 | $141 |
| SG&A Expenses | $24 | $186 | $163 | $159 |
| Sales & Mktg Exp. | $24 | $20 | $19 | $19 |
| Other Operating Expenses | $177 | $14 | $12 | $12 |
| Operating Expenses | $200 | $199 | $175 | $172 |
| Operating Income | $56 | $47 | $49 | $46 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | $21 | $27 | $21 | $12 |
| Pre-Tax Income | $77 | $75 | $70 | $57 |
| Tax Expense | $25 | $23 | $22 | $18 |
| Net Income | $40 | $41 | $39 | $29 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.2 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.2 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $18 | $18 | $15 | $14 |
| EBITDA | $95 | $65 | $64 | $60 |
| % Margin | 2.6% | 1.8% | 1.9% | 1.8% |